Harrow Health Inc (HROW)
Healthcare
Drug Manufacturers - Specialty & Generic
38.80 $
-0.4%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Harrow Health Inc (HROW)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 75.9% of the shares are freely tradable; institutional investors hold 58.9%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
58.9%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
15.5%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
75.9%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
21.8%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
37Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Opaleye Management Inc | 7.60 | 2,832,230 | -27.5 | 03/31/2026 |
| BlackRock Inc | 6.85 | 2,552,759 | -0.6 | 03/31/2026 |
| Vanguard Group Inc | 5.16 | 1,921,683 | +2.7 | 12/31/2025 |
| Private Capital Management, LLC | 4.19 | 1,562,000 | -15.3 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.76 | 1,403,056 | +0.0 | 03/31/2026 |
| Luxor Capital Group, LP | 3.00 | 1,119,400 | +22.0 | 03/31/2026 |
| State Street Corp | 2.29 | 855,047 | +9.1 | 03/31/2026 |
| Geode Capital Management, LLC | 2.29 | 852,034 | +8.5 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.69 | 1,001,445 | +0.0 | 04/30/2026 |
| iShares Russell 2000 ETF | 2.02 | 753,434 | +0.9 | 05/29/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.